Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Clinical trial NCT05899179 · COMPLETED

Trial details

NCT number: NCT05899179
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Latent Tuberculosis Infection

Start date: 2023-08-03
Primary completion: 2025-07-07
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.